The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat

Journal of Pediatric Gastroenterology and Nutrition

Volumn 26, Issue 5, 1998, Pages 489-495

  Lloyd Still, John D ^a,b   Uhing, Michael R ^a   Arango, Valerie ^a   Fusaro, Aldo ^a   Kimura, Robert E ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Fibrosing colonopathy; Oleic acid; Reserpine

Indexed keywords

OLEIC ACID; PANCREAS ENZYME; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENTEROPATHY; EOSINOPHILIA; INTESTINE MUCOSA PERMEABILITY; INTESTINE NECROSIS; LIVER NODULE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL MEMBRANE PERMEABILITY; EOSINOPHILIA; INTESTINAL DISEASES; INTESTINES; LIPASE; LIVER; NECROSIS; OLEIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RESERPINE;

EID: 0031921582     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199805000-00001     Document Type: Article

References (31)

1. FitzSimmons S, Freiman J. Colonic strictures in patients with cystic fibrosis: Results of a survey of 114 cystic fibrosis care centers in the United States. J Pediatr Gastroenterol Nutr 1995;22:153-6.
2. Smyth RL, van Velzen D, Smyth AR, et al. Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. Lancet 1994;343:85-6.
3. Lloyd-Still J. Cystic fibrosis and colonie strictures - a new 'iatrogenic' disease (editorial). J Clin Gastroenterol 1995;21:2-5.
4. Schwarzenberg SJ, Wielinske CL, Carpenter BLM, et al. Cystic fibrosis-associated colitis and fibrosing colonopathy (CFCFC): Presentation, clinical course and management. J Pediatr 1995;127: 565-70.
5. van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996;72(suppl 2):39-48.
6. Leclercq-Foucart J, Forget PP, Van Cutsem JL. Lactulose-rhamnose intestinal permeability in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1987;6:66-70.
7. Leclercq-Foucart J, Forget P, Sodoyez-Goffaux F, et al. Intestinal permeability to (51 Cr) EDTA in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1986;5:384-7.
8. Kimura R, Lapine TR, Gooch WM. Portal venous and aortic glucose and lactate changes in a chronically catheterised rat. Pediatr Res 1988;23:235-40.
9. Martinez JR, Martinez AM. The reserpine-treated rat as an experimental animal model for cystic fibrosis: Abnormal Cl transport in pancreatic acinar cells. Pediatr Res 1988;24:427-32.
10. McCurdy RE, Martinez R. The chronically reserpinised rat as a model for cystic fibrosis: Alterations in pancreatic enzyme secretion and storage. Pediatr Res 1981;15:1308-13.
11. Park CM, Reid PE, Owen DA, et al. Morphological and histochemical changes in intestinal mucosa in the reserpine-treated rat model of cystic fibrosis. Exp Mol Pathol 1987;47:1-12.
12. Crissinger KD, Tso P. The role of lipids in ischemia/reperfusion-induced changes in mucosal permeability in developing piglets. Gastroenterology 1992;102:1693-9.
13. Velasquez OR, Henninger K, Fowler M, et al. Oleic acid-induced mucosal injury in developing piglet intestine. Am J Physiol 1993; 264:G576-82.
14. Hubbard VS, Dunn DG, di Sant' Agnese PA, et al. Abnormal fatty acid composition of plasma lipids in cystic fibrosis: A primary or secondary defect? Lancet 1977;2:1302-4.
15. Lloyd-Still JD, Johnson SB, Holman RT. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants. Am J Clin Nutr 1991;54:1029-35.
16. Farrell PM, Mischler EH, Engle MJ, et al. Fatty acid abnormalities in cystic fibrosis. Pediatr Res 1985;19:104-9.
17. Sanjurjo P, Allue X, Rodriguez-Soriano J. Fatty-acid composition of lecithin fraction of mucus in cystic fibrosis. Lancet 1977;1:752.
18. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
19. Keshvarzian A, Doria MI, Sedghi S, et al. Mitomycin C-induced colitis in rats: A new animal model of acute colonic inflammation implicating reactive oxygen species. J Lab Clin Med 1992;120: 778-91.
20. Followill DS, Kester D, Travis EL. Histological changes in mouse colon after single and split-dose irradiation. Radiat Res 1993;136: 280-8.
21. Smyth RL, Ashby D, O'Hea U, et al. Fibrosing colonopathy in cystic fibrosis: Results of a case-control study. Lancet 1996;346: 1247-65.
22. FitzSimmons SC, Burkhart GA, Borowitz D, et al. High dose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997;336:1283-9.
23. Lloyd-Still J. Crohn's disease and cystic fibrosis. Dig Dis Sci 1994;39:880-5.
24. Uhing M, Lloyd-Still JD, Kimura R. An improved method of using the chronically reserpinised rat as a model for cystic fibrosis (CF) 1998 (submitted for publication).
25. Murakami M, Takada K, Muranishi S. Further mechanistic study on intestinal absorption enhanced by unsaturated fatty acids: Reversible effect by sulfhydryl modification. Biochim Biophys Acta 1992;1117:83-9.
26. Pawel BR, de Chadarevian JP, Franco ME. The pathology of fibrosing colonopathy of Cystic Fibrosis: A study of 12 cases and review of the literature. Hum Pathol 1997;28:395-9.
27. Graham MF, Drucker DEM, Diegelmann F, et al. Collagen synthesis by human intestinal smooth muscle cells in culture. Gastroenterology 1987;92:400-5.
28. Graham MF, Bryson GR, Diegelmann RF. Transforming growth factor b selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology 1990;99:447-53.
29. Morgan HR. Pathologic changes produced in rabbits by a toxic somatic antigen cleaved from Erbettella typhosa. Am J Pathol 1943;19:135-40.
30. Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology 1993;104:759-71.
31. Konstan MW, Byard PJ, Hoppel CL, et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332: 848-54.